Minerva Neurosciences
NERV
80 hedge funds and large institutions have $103M invested in Minerva Neurosciences in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 29 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
1.34% less ownership
Funds ownership: 10.19% → 8.85% (-1.3%)
11% less funds holding
Funds holding: 90 → 80 (-10)
34% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 29
40% less call options, than puts
Call options by funds: $3.4M | Put options by funds: $5.69M
47% less capital invested
Capital invested by funds: $192M → $103M (-$89.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.32M |
| 3 |
Goldman Sachs
New York
|
+$4.78M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.07M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$7.23M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.78M |
| 3 |
IVAV
Index Venture Associates V
St. Helier, Channel Islands,
Jersey
|
-$5.56M |
| 4 |
Millennium Management
New York
|
-$5.41M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$4.14M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCP
101
GSA Capital Partners
London,
United Kingdom
| – | -$61K | -1,260 | Closed |
|
102
BAMCO Inc
New York
| – | -$23K | -475 | Closed |
|
103
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
| – | -$22K | -459 | Closed |
|
|
MLICM
104
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$13.9K | -289 | Closed |
|
|
DWA
105
Dorsey Wright & Associates
Pasadena,
California
| – | -$8K | -170 | Closed |
|
|
MAM
106
Meeder Asset Management
Dublin,
Ohio
| – | -$5K | -129 | Closed |
|
|
TWA
107
TCI Wealth Advisors
Tucson,
Arizona
| – | -$5.87K | -100 | -88% |
|
|
PCM
108
Prelude Capital Management
New York
| – | +$763 | +13 | New |
|
|
VFA
109
Valeo Financial Advisors
Carmel,
Indiana
| – | +$763 | +13 | New |
|
NERV Hedge Fund Activity: Q2 2020 in Review
80 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2020, worth a combined $103M — down 47% from $192M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of NERV and 19 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 32 added.
The largest buyer was Vanguard Group, adding an estimated $11M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.23M sold.
- 80 institutional investors held Minerva Neurosciences (NERV) as of Q2 2020, down from 90 in Q1 2020.
- Funds reported $103M of Minerva Neurosciences stock for Q2 2020, down 47% quarter-over-quarter.
- 19 funds opened new Minerva Neurosciences positions in Q2 2020 and 29 closed out, a net change of -10 holders.
- The largest Minerva Neurosciences buyer in Q2 2020 was Vanguard Group, an estimated $11M added.
- The largest Minerva Neurosciences seller in Q2 2020 was Franklin Resources, an estimated $7.23M sold.
Based on aggregated 13F filings for Q2 2020.